AbbottABT
NYSEPharmaceuticals
No cached AI snapshot yet for ABT.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
115,000 employees1.74B shares outstandinglisted 1949-04-19dividend yield 2.69%
Next earnings ~May 5, 2026 · Ex-dividend Apr 15, 2026 · Dividend $0.63 quarterly
About Abbott
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Latest News
Is Abbott (ABT) the Best Longevity Stock to Buy Now?
Abbott Laboratories declares $0.63 dividend
Abbott declares 410th consecutive quarterly dividend
Abbott declares 410th consecutive quarterly dividend
Abbott Laboratories Remains Structurally Undervalued
The Fed May Have A Hawkish Surprise For Markets This Week
Related Stocksin Pharmaceuticals
Ready to see the live AI view on ABT?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing ABT side-by-side with live signals.